Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111201507 | 11120150 | 7 | F | 2000 | 20160818 | 20150518 | 20160824 | EXP | PHHY2015BR053775 | NOVARTIS | 0.00 | F | Y | 103.00000 | KG | 20160824 | CN | COUNTRY NOT SPECIFIED | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111201507 | 11120150 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, Q2MO, EVERY 2 MONTHS, EVERY OTHER MONTH | U | 21008 | 30 | MG | VIAL | ||||||
| 111201507 | 11120150 | 2 | C | CABERGOLINE. | CABERGOLINE | 1 | Oral | 1 DF, QW | Y | 0 | 1 | DF | TABLET | /wk | |||||
| 111201507 | 11120150 | 3 | C | ENALAPRIL | ENALAPRIL | 1 | Oral | 2 DF, QD | 0 | 2 | DF | TABLET | QD | ||||||
| 111201507 | 11120150 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 3 DF, QD | 0 | 3 | DF | TABLET | QD | ||||||
| 111201507 | 11120150 | 5 | C | INSULIN RAPID | INSULIN NOS | 1 | Unknown | 30 IU, TID | 0 | 30 | IU | TID | |||||||
| 111201507 | 11120150 | 6 | C | NPH INSULIN | INSULIN BEEF | 1 | Unknown | 3 DF, QD | 0 | 3 | DF | QD | |||||||
| 111201507 | 11120150 | 7 | C | LEVOTIROXIN | 2 | Unknown | U | 0 | |||||||||||
| 111201507 | 11120150 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 111201507 | 11120150 | 9 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111201507 | 11120150 | 1 | Acromegaly |
| 111201507 | 11120150 | 2 | Acromegaly |
| 111201507 | 11120150 | 3 | Hypertension |
| 111201507 | 11120150 | 4 | Diabetes mellitus |
| 111201507 | 11120150 | 5 | Diabetes mellitus |
| 111201507 | 11120150 | 6 | Diabetes mellitus |
| 111201507 | 11120150 | 7 | Product used for unknown indication |
| 111201507 | 11120150 | 8 | Product used for unknown indication |
| 111201507 | 11120150 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111201507 | 11120150 | HO |
| 111201507 | 11120150 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111201507 | 11120150 | Anxiety | |
| 111201507 | 11120150 | Arthralgia | |
| 111201507 | 11120150 | Bladder mass | |
| 111201507 | 11120150 | Bursitis | |
| 111201507 | 11120150 | Cardiac disorder | |
| 111201507 | 11120150 | Cholelithiasis | |
| 111201507 | 11120150 | Headache | |
| 111201507 | 11120150 | Osteoarthritis | |
| 111201507 | 11120150 | Product use issue | |
| 111201507 | 11120150 | Tendonitis | |
| 111201507 | 11120150 | Thyroid mass |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111201507 | 11120150 | 1 | 2000 | 2007 | 0 | |
| 111201507 | 11120150 | 2 | 2004 | 2007 | 0 | |
| 111201507 | 11120150 | 5 | 1989 | 0 | ||
| 111201507 | 11120150 | 6 | 1989 | 0 |